CA-4948 in Combination With FOLFOX/PD-1 Inhibitor +/- Trastuzumab for Untreated Unresectable Gastric and Esophageal Cancer
Washington University School of Medicine
Washington University School of Medicine
ViroMissile, Inc.
Genentech, Inc.
Eli Lilly and Company
Baylor College of Medicine
Nanjing Sanhome Pharmaceutical, Co., Ltd.
SystImmune Inc.
Eli Lilly and Company
Henry Ford Health System
Pfizer
M.D. Anderson Cancer Center
AbbVie
Sichuan Baili Pharmaceutical Co., Ltd.
Jonsson Comprehensive Cancer Center
Anhui Provincial Hospital
Ascentage Pharma Group Inc.
Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)
Columbia University
University of Utah
Zumutor Biologics Inc.
Taiho Pharmaceutical Co., Ltd.
National University Hospital, Singapore
Myeloid Therapeutics
Chongqing Precision Biotech Co., Ltd
Chongqing Precision Biotech Co., Ltd
Chongqing Precision Biotech Co., Ltd